News | Susan G. Komen®️

Susan G. Komen Newsroom

Get the latest news and updates from Susan G. Komen

All News

News Releases

Susan G. Komen® to Host MORE THAN PINK Walk in San Antonio this Fall

September 19, 2024

Susan G. Komen® to Host MORE THAN PINK Walk in Oklahoma City this Fall

September 19, 2024

Susan G. Komen® to Host Fort Worth More Than Pink Walk and Dallas Race for the Cure

September 19, 2024

Susan G. Komen(R) to Host MORE THAN PINK Walk in the Bay Area this Fall

September 18, 2024

Susan G. Komen® To Host MORE THAN PINK Walk in Vermont This Fall

September 13, 2024

New Breast Density Reporting Requirement Empowers Women with Vital Information; Susan G. Komen® Urges Access to Affordable Care

September 10, 2024

Susan G. Komen® to Host MORE THAN PINK Walk in Nashville this Fall

September 6, 2024

Susan G. Komen® to Host MORE THAN PINK Walk in Orange County this Fall

September 6, 2024

1 2 3 4 5 6 7 … 32

Recent Podcasts

[00:00:00] Adam Walker: From Susan G Komen, this is Real Pink. A podcast exploring real stories, struggles, and triumphs related to breast cancer. We’re taking the conversation from the doctor’s office to your living room. [00:00:17] This is Real Talk, a podcast conversation where we’re digging deep into breast cancer and the realities patients and…

Getting to YesMon, 25 Nov 2024
On today’s episode, we are discussing a topic that affects most women with hormone receptor-positive, early-stage breast cancer after they finish their initial treatment and begin navigating survivorship. To lower the risk of recurrence, most women begin taking anti-estrogen therapy, also called hormone therapy or endocrine therapy, but these treatments do not come without the risk of side effects. When side effects become severe, survivors may be faced with the task of weighing the benefits of hormone therapy against the associated side effects. This can be challenging and may even lead them to wonder how much longer they need to continue on the medication. Joining us today to discuss how patients and providers can balance fear of recurrence against potential side effects of treatment and how genomic testing can help guide treatment decisions is a Nurse Practitioner at Memorial Sloan-Kettering Cancer Center, Adriana Olivo.

Balancing Fear of Recurrence vs. Treatment Side Effects in SurvivorshipMon, 18 Nov 2024
[00:00:00] Adam Walker: This episode of the Real Pink Podcast is brought to you by AstraZeneca. AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to understand cancer and all of its complexities to discover, develop, and deliver life changing medicines to patients.…

How Political Determinants of Health Impact Us AllMon, 11 Nov 2024